A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-line chemotherapy for advanced pancreatic cancer in South Korea

BACKGROUND: This phase III trial compared the efficacy and safety of gemcitabine plus capecitabine (GemCap) versus single-agent gemcitabine (Gem) in advanced pancreatic cancer as first-line chemotherapy. METHODS: A total of 214 advanced pancreatic cancer patients were enrolled from 16 hospitals in S...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Medicine (Baltimore)
Huvudupphovsmän: Lee, Hee Seung, Chung, Moon Jae, Park, Jeong Youp, Bang, Seungmin, Park, Seung Woo, Kim, Ho Gak, Noh, Myung Hwan, Lee, Sang Hyub, Kim, Yong-Tae, Kim, Hyo Jung, Kim, Chang Duck, Lee, Dong Ki, Cho, Kwang Bum, Cho, Chang Min, Moon, Jong Ho, Kim, Dong Uk, Kang, Dae Hwan, Cheon, Young Koog, Choi, Ho Soon, Kim, Tae Hyeon, Kim, Jae Kwang, Moon, Jieun, Shin, Hye Jung, Song, Si Young
Materialtyp: Artigo
Språk:Inglês
Publicerad: Wolters Kluwer Health 2017
Ämnen:
4500
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5228666/
https://ncbi.nlm.nih.gov/pubmed/28072706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000005702
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk